H.B. Fuller reaffirms Advanced Medical Solutions deal will close by end-2026 as Q3 EBITDA rises 9%
H.B. Fuller reaffirmed that its pending acquisition of medical technology group Advanced Medical Solutions is expected to close before the end of 2026, and confirmed plans to cut manufacturing sites from 82 in 2024 to about 62 by year-end, with 55 as the long-term target. The US adhesives maker, which supplies packaging, hygiene and industrial markets, reported fiscal Q3 2026 net revenue up 5.2% to USD 938m and adjusted EBITDA up 9% to USD 187m, with pricing offsetting weaker volumes and raw-material inflation. Full-year adjusted EBITDA guidance was set at USD 655m-670m.
Why this mattersA key adhesives supplier to packaging converters is redirecting capital toward medical technology while cutting its manufacturing footprint by a quarter.
- Pending acquisition of Advanced Medical Solutions expected to close before the end of 2026
- Manufacturing sites to fall from 82 in 2024 to about 62 by end 2026, with a long-term target of 55
- Q3 2026 net revenue rose 5.2% year on year to USD 938m
- Adjusted EBITDA rose 9% to USD 187m, with margin up 80 basis points to 19.9%
- Adjusted EPS rose 21% to USD 1.52
- Fiscal 2026 adjusted EBITDA guidance set at USD 655m-670m
Sources
fool.com